GleamWall
中文EN

venBio Partners LLC

SAN FRANCISCO CA · SEC CIK 0001776382

2026Q22026Q1 9 earlier quarters 🔒
$519.38M2026Q2 reported value
7Positions
100.0%Top 10 weight · largest 30.9%
1 / 1New / sold out
Reported value over time$519.38M2026Q2
26Q126Q2

All 11 quarters on paid plans 🔒

Top 10 holdings % of portfolio

PHVS 30.9%
PBLS 27.8%
ALMS 24.5%
ACHV 7.4%
ALXO 5.1%
HRMY 3.3%
LYEL 0.9%

2026Q2 top buys estimated at quarter-end value

ACHV New+$38.62M
PHVS Added+$142,677

2026Q2 top sells estimated at quarter-end value

ARTV Sold out-$3.42M
HRMY Reduced-$618,970

2026Q2 holdings click a header to sort

Export CSV 🔒
TickerNameValue ▼WeightSharesShare changeChangeEst. flowAction
PHVS PHARVARIS N V $160.57M30.92%4,643,430 4,1260.1% $142,677 Added
PBLS PARABILIS MEDICINES INC $144.15M27.75%5,266,697 5,266,697— — First reported
ALMS ALUMIS INC $127.43M24.53%4,528,408 00.0% — Unchanged
ACHV ACHIEVE LIFE SCIENCE INC $38.62M7.44%5,914,720 5,914,720— $38.62M New
ALXO ALX ONCOLOGY HLDGS INC $26.67M5.14%12,884,638 00.0% — Unchanged
HRMY HARMONY BIOSCIENCES HLDGS IN $17.19M3.31%472,194 -17,000-3.5% -$618,970 Reduced
LYEL LYELL IMMUNOPHARMA INC $4.74M0.91%337,697 00.0% — Unchanged
ARTV ARTIVA BIOTHERAPEUTICS INC $00.00%0 -531,337-100.0% -$3.42M Sold out